Net Income Per Share (Tables)

3 Months Ended

Mar. 31, 2023

Earnings Per Share [Abstract]

Schedule of computation of basic and diluted net income per share

The following table shows the computation of basic and diluted net income per share for the three months ended March 31, 2023 and 2022:

	Three Months Ended March 31,
(In thousands except per share data)	2023		2022
Numerator:
Net income attributable to Innoviva stockholders, basic	$	34,865	$	15,773
Add: interest expense on 2023 Notes, net of tax effect		81		1,021
Add: interest expense on 2025 Notes, net of tax effect		1,169		1,164
Add: interest expense on 2028 Notes, net of tax effect		1,459		384
Net income attributable to Innoviva stockholders, diluted	$	37,574	$	18,342
Denominator:
Weighted-average shares used to compute basic net income    per share attributable to Innoviva stockholders		67,786		69,544
Dilutive effect of 2023 Notes		757		10,155
Dilutive effect of 2025 Notes		11,150		11,150
Dilutive effect of 2028 Notes		9,956		2,765
Dilutive effect of options and awards granted under equity    incentive plan and employee stock purchase plan		139		116
Weighted-average shares used to compute diluted net income    per share attributable to Innoviva stockholders		89,788		93,730
Net income per share attributable to Innoviva stockholders
Basic	$	0.51	$	0.23
Diluted	$	0.42	$	0.20

Schedule of anti-dilutive securities

The following common stock equivalents were not included in the computation of diluted net income per share because their effect was anti-dilutive for the periods presented:

	Three Months Ended March 31,
(In thousands)	2023		2022
Outstanding options and awards granted under equity incentive    plan and employee stock purchase plan		1,326		386
Outstanding stock warrant		591		—
Total		1,917		386